Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy

Immune-related adverse events (irAEs) can impair the effectiveness and safety of immune checkpoint inhibitors (ICIs) and restrict the clinical applications of ICIs in oncology. The predictive biomarkers of irAE are urgently required for early diagnosis and subsequent management. The exact mechanism...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Xiujing He, Jing Yu, Hubing Shi
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/25a5360c76b84b09966f0ca0586bfb3e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!